Skip to main content
. 2023 Jan 31;23:50. doi: 10.1186/s12883-023-03091-z

Table 2.

Comparison of baseline data between patients with and without 3-month PSD

Variables With PSD (n = 91) Without PSD (n = 235) P value
Demographic characteristics,
 Age, year 68.1 ± 10.8 66.0 ± 11.5 0.126
 Male, % 42 (46.2) 126 (53.6) 0.226
 Education < 12 years, % 59 (64.8) 113 (48.1) 0.007
Risk factors, %
 Hypertension 69 (75.8) 171 (72.8) 0.547
 Diabetes mellitus 40 (44.0) 43 (18.3)  < 0.001
 Hyperlipidemia 14 (15.4) 55 (23.4) 0.112
 Coronary heart disease 16 (17.6) 30 (12.8) 0.262
 Current smoking 34 (37.4) 103 (43.8) 0.289
Clinical data
 Systolic blood pressure, mmHg 136.9 ± 24.9 136.0 ± 17.4 0.640
 Diastolic blood pressure, mmHg 82.4 ± 9.5 82.0 ± 10.1 0.677
 Body mass index, kg/m2 24.6 ± 2.7 24.2 ± 2.4 0.198
 Baseline NIHSS, score 5.0 (3.0, 8.0) 5.0 (2.0, 8.0) 0.048
 Advanced liver fibrosis, % 32 (35.2) 48 (20.4) 0.006
 FIB-4 index 2.3 (1.3, 3.1) 1.8 (1.3, 2.5) 0.032
 Stroke subtypes, % 0.321
 Large artery atherosclerosis 42 (46.2) 107 (45.5)
 Cardioembolism 20 (22.0) 43 (18.3)
 Small vessel occlusion 20 (22.0) 71 (30.2)
Others 9 (9.9) 14 (6.0)
Side of infarction, %
 Left 46 (50.5) 119 (50.6) 0.989
 Right 53 (58.2) 128 (54.5) 0.539
Laboratory data
 Platelet, 109/L 177.5 ± 60.2 186.2 ± 57.4 0.225
 Aspartate transaminase, U/L 31.8 ± 24.2 28.2 ± 16.9 0.135
 Alanine transaminase, U/L 34.0 ± 21.3 32.0 ± 20.0 0.429
 Total cholesterol, mmol/L 4.0 ± 1.1 4.0 ± 1.1 0.987
 Triglyceride, mmol/L 1.4 (1.1, 1.8) 1.3 (1.0, 1.8) 0.392
 High-density lipoprotein, mmol/L 1.0 ± 0.2 1.0 ± 0.2 0.228
 Low-density lipoprotein, mmol/L 2.5 (1.9, 3.0) 2.3 (1.8, 2.9) 0.311
 Blood glucose, mmol/L 5.3 ± 1.7 5.4 ± 1.6 0.543
 Hs-CRP, mg/L 5.6 (2.0, 7.0) 4.0 (1.0, 6.0) 0.015

NIHSS National Institutes of Health Stroke Scale, PSD post-stroke depression